[
    [
        {
            "time": "",
            "orginal_text": "2021年基金一季报专题研究之二：四类基金画像 短跑、长跑、降仓、管大钱",
            "features": {
                "keywords": [
                    "基金",
                    "一季报",
                    "短跑",
                    "长跑",
                    "降仓"
                ],
                "sentiment_score": 0.6,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "金融"
                ],
                "causal_factor": "true",
                "causal_impact": "neutral",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "original_text": "2021年基金一季报专题研究之二：四类基金画像 短跑、长跑、降仓、管大钱",
            "scores": {
                "News_content": "2021年基金一季报专题研究之二：四类基金画像 短跑、长跑、降仓、管大钱",
                "Correlation": 4,
                "Sentiment": 5,
                "Importance": 6,
                "Impact": 4,
                "Duration": 5,
                "Entity_Density": 2,
                "Market_Scope": 8,
                "Time_Proximity": 3,
                "Headline_Structure": 6,
                "Source_Recency": 3
            }
        },
        {
            "time": "",
            "orginal_text": "【牛人重仓】泰格医药: 牛人重仓绩优股今年以来融资余额增仓25%以上，今日资金流入658.04万元，北向资金持股10511.28万股，融资余额90960.7万元；前3个交易日，北向资金增持-71.94万股，融资额增加2535.87万元，主力资金净流入17158.57万元",
            "features": {
                "keywords": [
                    "泰格医药",
                    "融资余额",
                    "北向资金",
                    "主力资金",
                    "增仓"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "original_text": "【牛人重仓】泰格医药: 牛人重仓绩优股今年以来融资余额增仓25%以上，今日资金流入658.04万元，北向资金持股10511.28万股，融资余额90960.7万元；前3个交易日，北向资金增持-71.94万股，融资额增加2535.87万元，主力资金净流入17158.57万元",
            "scores": {
                "News_content": "【牛人重仓】泰格医药: 牛人重仓绩优股今年以来融资余额增仓25%以上，今日资金流入658.04万元，北向资金持股10511.28万股，融资余额90960.7万元；前3个交易日，北向资金增持-71.94万股，融资额增加2535.87万元，主力资金净流入17158.57万元",
                "Correlation": 9,
                "Sentiment": 8,
                "Importance": 8,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 9,
                "Market_Scope": 4,
                "Time_Proximity": 9,
                "Headline_Structure": 8,
                "Source_Recency": 9
            }
        },
        {
            "time": "",
            "orginal_text": "券商晨会观点速递",
            "features": {
                "keywords": [
                    "券商",
                    "晨会",
                    "观点"
                ],
                "sentiment_score": 0.5,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [],
                "causal_factor": "false",
                "causal_impact": "",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "original_text": "券商晨会观点速递",
            "scores": {
                "News_content": "券商晨会观点速递",
                "Correlation": 3,
                "Sentiment": 5,
                "Importance": 4,
                "Impact": 3,
                "Duration": 4,
                "Entity_Density": 2,
                "Market_Scope": 7,
                "Time_Proximity": 6,
                "Headline_Structure": 5,
                "Source_Recency": 6
            }
        },
        {
            "time": "",
            "orginal_text": "中信建投：再次强调疫苗产业链投资机会",
            "features": {
                "keywords": [
                    "中信建投",
                    "疫苗",
                    "产业链",
                    "投资机会"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "original_text": "中信建投：再次强调疫苗产业链投资机会",
            "scores": {
                "News_content": "中信建投：再次强调疫苗产业链投资机会",
                "Correlation": 7,
                "Sentiment": 7,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 5,
                "Market_Scope": 8,
                "Time_Proximity": 7,
                "Headline_Structure": 7,
                "Source_Recency": 8
            }
        }
    ]
]